Congratulations to our Research Fellow Dr Crispin and colleagues as Hansa Medical who take their method of improving anti-cancer therapy toward clinical trials, marking the the next steps to improve cancer treatments. Dr Max Crispin holds the Against Breast Cancer Fellowship in Cancer Therapeutics at Oriel College, Oxford, which was awarded to support Dr Crispin’s work …
Read moreResearch funded by Against Breast Cancer has been published in the latest edition of the British Journal of Cancer confirming a new blood test can detect if breast cancer has spread to other parts of the body. The test distinguished between patients with secondary breast cancer and those who remained disease free for 5 years after …
Read more
Antibodies engineered to carry anti-cancer drugs are increasingly being used to treat a variety of diseases, including breast cancer, and future treatment might not only be used at lower doses, but also have reduced side effects too. Researchers at the University of Oxford have demonstrated in the laboratory that destruction of cancer cells can be …
Read more
Redesigned Bi-Specific antibodies may offer new hope against secondary breast cancer. We are delighted to announce that we are now funding a 4-year project at Oxford University to make new breast cancer treatments that stick to cancerous breast cells that have spread throughout the body; a currently incurable condition termed metastases, or secondary spread. Dr. …
Read more
You may be aware that there are different types of breast cancer, but do you know why they need to be treated in different ways? A breast is comprised of many types of cells, some of which are programmed to respond to different growth stimuli in order to function as part of the healthy reproductive …
Read more